Today, the U.S. Food and Drug Administration (FDA) published the guidance snapshot and podcast for the draft guidance “Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing.”
Today, the U.S. Food and Drug Administration (FDA) published the guidance snapshot and podcast for the draft guidance “Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing.”